Targeted Medical Valuation
| TRGM Stock | USD 0.0001 0.00 0.00% |
Targeted Medical seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of Targeted Medical from inspecting the company fundamentals such as Return On Asset of -0.48, shares owned by insiders of 61.64 %, and Current Valuation of 5.54 M as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Targeted Medical's price fluctuation is very steady at this time. Calculation of the real value of Targeted Medical is based on 3 months time horizon. Increasing Targeted Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Targeted pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Targeted Medical. Since Targeted Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Targeted Pink Sheet. However, Targeted Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.4E-5 | Hype 1.0E-4 | Naive 1.0E-4 |
The intrinsic value of Targeted Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Targeted Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Targeted Medical helps investors to forecast how Targeted pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Targeted Medical more accurately as focusing exclusively on Targeted Medical's fundamentals will not take into account other important factors: Targeted Medical Total Value Analysis
Targeted Medical is at this time forecasted to have valuation of 5.54 M with market capitalization of 322.99 K, debt of 670.9 K, and cash on hands of 82.64 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Targeted Medical fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
5.54 M | 322.99 K | 670.9 K | 82.64 K |
Targeted Medical Investor Information
About 62.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.11. Targeted Medical had not issued any dividends in recent years. Targeted Medical is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Targeted Medical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Targeted Medical has an asset utilization ratio of 216.76 percent. This suggests that the Company is making $2.17 for each dollar of assets. An increasing asset utilization means that Targeted Medical is more efficient with each dollar of assets it utilizes for everyday operations.Targeted Medical Ownership Allocation
Targeted Medical shows a total of 30.19 Million outstanding shares. Targeted Medical has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 61.64 % of Targeted Medical outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Targeted Medical Profitability Analysis
The company reported the previous year's revenue of 5.26 M. Net Loss for the year was (3.04 M) with profit before overhead, payroll, taxes, and interest of 3.17 M.About Targeted Medical Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Targeted Medical. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Targeted Medical based exclusively on its fundamental and basic technical indicators. By analyzing Targeted Medical's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Targeted Medical's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Targeted Medical. We calculate exposure to Targeted Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Targeted Medical's related companies.Targeted Medical Pharma, Inc., a specialty pharmaceutical company, doing business as Physician Therapeutics, develops and commercializes amino acid based medications to physicians, pharmacies, and patients in the United States. Targeted Medical Pharma, Inc. was founded in 1996 and is headquartered in Los Angeles, California. Targeted Medical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 30 people.
8 Steps to conduct Targeted Medical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Targeted Medical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Targeted Medical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Targeted Medical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Targeted Medical's revenue streams: Identify Targeted Medical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Targeted Medical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Targeted Medical's growth potential: Evaluate Targeted Medical's management, business model, and growth potential.
- Determine Targeted Medical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Targeted Medical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Other Information on Investing in Targeted Pink Sheet
Targeted Medical financial ratios help investors to determine whether Targeted Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Targeted with respect to the benefits of owning Targeted Medical security.